← Back to Clinical Trials
Recruiting NCT04719026

NCT04719026 PERIODONTAL HEALTH IN PATIENTS ACUTELY ADMITTED FOR MYOCARDIAL INFARCTION: A CASE CONTROL STUDY

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04719026
Status Recruiting
Phase
Sponsor University of Aberdeen
Condition Myocardial Infarction, Acute
Study Type OBSERVATIONAL
Enrollment 320 participants
Start Date 2018-02-16
Primary Completion 2027-03-14

Eligibility & Interventions

Sex All sexes
Min Age 20 Years
Max Age 90 Years
Study Type OBSERVATIONAL
Interventions
Full-mouth periodontal examination using computerised Florida probe

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 320 participants in total. It began in 2018-02-16 with a primary completion date of 2027-03-14.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Heart attack remains a major cause of death in adult population worldwide and especially within Scotland. A large portion of the general population has an increased risk of suffering from a heart attack because of their genetic make-up, disease profile and lifestyle choices. Literature suggests that apart from these known risk factors, long-standing inflammation (reaction of tissues to infection or injury) elsewhere in the body may be responsible for heart attacks. It has been suggested that gum disease may be one such condition. If left untreated, gum disease may expose the entire body to a long-term inflammatory burden where inflammatory molecules can disseminate from the gums into the bloodstream and affect various body structures. This study explores the influence of gum disease on the risk of heart attack by comparing the gum health of participants who recently had a heart attack to the gum health of participants with no history of heart problems after accounting for other risk factors. Findings will provide critical information for the design of our forthcoming study to establish the effect of treatment of gum disease on the risk of heart attack, and its cost-effectiveness. Ultimately this research will tackle another risk factor for heart attacks and thus inform enhancement of public health prevention strategies.

Eligibility Criteria

Inclusion Criteria: * cases: Patients aged 20-90 admitted with acute myocardial infarction * controls: Dental patients, aged 20-90, matched to patients in the case study group for age, gender (±7) and risk factors for coronary artery disease (hypertension, obesity, diabetes, smoking, hypercholesterolaemia) but with no history of myocardial infarction) Exclusion Criteria: * Severe co-morbidities, Inability to consent, pregnant participants will be excluded, participants with other systemic inflammatory diseases, patients taking antimicrobials or antibiotics in last three years, patients taking medications, such as cyclosporine, calcium channel blockers, phenytoin, immunocompromised patients, patients with malignancies, patinets with type-2 or type-3 hypersensitivities

Frequently Asked Questions

Who can join the NCT04719026 clinical trial?

This trial is open to participants of all sexes, aged 20 Years or older, up to 90 Years, studying Myocardial Infarction, Acute. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04719026 currently recruiting?

Yes, NCT04719026 is actively recruiting participants. Visit ClinicalTrials.gov or contact University of Aberdeen to inquire about joining.

Where is the NCT04719026 trial being conducted?

This trial is being conducted at Aberdeen, United Kingdom.

Who is sponsoring the NCT04719026 clinical trial?

NCT04719026 is sponsored by University of Aberdeen. The trial plans to enroll 320 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology